Arenaviruses: Hemorrhagic Fevers and Meningitis from Rodent-Borne Viruses

Arenaviruses are enveloped, bisegmented, single-stranded RNA viruses (family Arenaviridae), named for the sandy ("arena") appearance of ribosomes within virions. They cause a spectrum of disease from aseptic meningitis to severe hemorrhagic fevers. Two major groups exist: Old World (Africa, Europe, Asia) and New World (Americas).

Old World Arenaviruses

  • Lassa virus: Endemic in West Africa. 100,000–300,000 infections annually, ~5,000 deaths. Reservoir: Mastomys natalensis (multimammate rat). Person-to-person transmission via body fluids. Clinical features: fever, pharyngitis, retrosternal pain, hemorrhage, shock, and sensorineural deafness (25% of survivors). Early IV ribavirin reduces mortality. Vaccines in trials.
  • Lymphocytic choriomeningitis virus (LCMV): Worldwide. Mus musculus reservoir. Usually asymptomatic or flu-like; can cause aseptic meningitis. Severe in immunocompromised; congenital infection leads to hydrocephalus and chorioretinitis. Important lab model for immunology.
  • Lujo virus: Southern Africa. Nosocomial outbreak in 2008; 80% case fatality rate.

New World Arenaviruses

  • Junín virus: Argentine hemorrhagic fever. Calomys rodents. Epidemics in 1950s–80s; now controlled by Candid #1 vaccine (live attenuated, >95% efficacy).
  • Machupo virus: Bolivian hemorrhagic fever. Similar ecology.
  • Guanarito virus: Venezuelan hemorrhagic fever.
  • Sabia virus: Brazilian hemorrhagic fever.
  • Whitewater Arroyo, Bear Canyon, Tamiami: North American; rare human disease.

Virology Essentials

  • Genome: L segment (~7.2 kb) encodes L (RdRp) and Z (matrix). S segment (~3.5 kb) encodes NP (nucleoprotein) and GPC (glycoprotein precursor → GP1/GP2).
  • Entry: GP1 binds α-dystroglycan (Old World) or transferrin receptor 1 (New World clade B).
  • Replication: Cytoplasmic; ambisense coding strategy.

Transmission

  • Rodent excreta (urine, feces, saliva) → aerosol, direct contact, fomites.
  • Person-to-person: Lassa, Lujo (body fluids, nosocomial).
  • Lab aerosol risk—BSL-3 (LCMV) to BSL-4 (Lassa, New World HF).

Clinical Spectrum

  • Mild febrile illness → hemorrhagic fever (capillary leak, coagulopathy, multi-organ failure).
  • Neurologic: meningitis, encephalitis, hearing loss.
  • Pregnancy: high fetal loss, maternal mortality.

Countermeasures

  • Ribavirin (early IV) for Lassa and New World HF.
  • Convalescent plasma (historical).
  • Vaccines: Candid #1 (Junín), ML29 (Lassa/LCMV chimeric, advanced preclinical), others in pipeline.
  • Rodent control, food storage, PPE, infection control.

Arenaviruses remain neglected tropical threats with pandemic potential. Surveillance, diagnostics, and vaccine development are global health priorities.

Viral Infections - Related Articles